Consejo Nacional de Salud

22 P Poole, J. Epirubicin And Cyclophosphamide,
Methotrexate And Fluorouracil As Adjuvant Therapy
For Early Breast Cancer. [Uk]: N Engl J Med
355;18, November 2006. Disponible En Www:
Http://Nejm.Org [Consulta: 17, Noviembre 2008]
23 Ivor, X. Results Of Randomised Phase Ii Studies
Comparing S16020 With Methotrexate In Patients
With Recurrent Head And Neck Cáncer [En
Línea]. Annals Of Oncology 14: 373–377. [Besançon
Cedex, France]: Annals Of Oncology, 2003.
Disponible En Www: Http://Annonc.Oxfordjournals.Org/Cgi/Content/Full/14/3/373
[Consulta:
17, Noviembre 2008].
24 Fransen, J. Influence Of Guideline Adherence On
Outcome In A Randomised Controlled Trial On
The Efficacy Of Methotrexate With Folate Supplementation
In Rheumatoid Arthritis.[ Nijmegen,
Netherlands]: University Medical Centre Nijmegen,
December 2003. P 1222-1226. Disponible
En Www: Http://Www.Ncbi.Nlm.Nih.Gov/Pub
med/15361375?Ordinalpos=150&Itool=Entrezs
ystem2.Pentrez.Pubmed.Pubmed_Resultspanel.
Pubmed_Defaultreportpanel.Pubmed_Rvdocsum
[Consulta: 17, Noviembre 2008].
25 Silverman,M.D. Leflunomide Or Methotrexatefor
Juvenile Rheumatoid Arthritis [En Linea].[Toronto]:
Toronto University, New England Journal
Of Medicine, April 2005. P1655-1666. Disponible
En Www: Http://Nejm.Org [Consultado: 17,
Noviembre 2008].
26 Vera, M. R. Methotrexate Versus Cyclosporine
In Moderateto-Severe Chronic Plaque Psoriasis.
[Amsterdam]: University Of Amsterdam, N Engl J
Med, August 2003. Disponible En Www: Http://
Search.Nejm.Org/Search?W=Methotrexate+For
+Psoriasis [Consulta: 19, Noviembre 2008].
27 Aviles, A. Interferon And Low Dose Methotrexateimprove
Outcome In Refractory Mycosis Fungoides/Sézary
Syndrome. [Mexico, Df]: Larchmont,
2007. Disponible En www.Http://Proquest.
umi.com [Consulta: 19, Noviembre 2008].
28 Stanulla M, Schaeffeler M, Flohr T, Cario G,
Schrauder A, Zimmermann M, Welte P, Ludwig
W-C, Bartram C R, Zanger U M, Eichelbaum M,
Schrappe M, Schwab M, Thiopurine Methyltransferase
(TPMT) Genotype and Early Treatment Response
to Mercaptopurine in Childhood Acute Lymphoblastic
Leukemia, JAMA. 2005;293:1485-1489
Wagstaff A J,Ibbotson T, Goa K L, Capecitabine:
A Review of its Pharmacology and Therapeutic
Efficacy in the Management of Advanced Breast
Cancer, Drugs 2003; 63 (2): 217-2360012-
6667/03/0002-0217/$33.00/ Adis International
Limited, Auckland, New Zealand
Martin Stanulla, MD, MScElke Schaeffeler, Ph-
DThomas Flohr, PhDGunnar Cario, MDAndré
Schrauder, MDMartin Zimmermann, PhDKarl
Welte, MDWolf-Dieter Ludwig, MDClaus R.
Bartram, MDUlrich M. Zanger, PhDMichel
Eichelbaum, MDMartin Schrappe, MDMatthias
Schwab, MD
29 Stanulla M, Schüneman H, Thioguanine versus
mercaptopurine in childhood ALL, The Lancet,
Volume 368, 2006, 9544, 1304-06, 2006
30 Stanulla M, Schüneman H, Thioguanine versus
mercaptopurine in childhood ALL, The Lancet,
Volume 368, 2006, 9544, 1304-06, 2006
31 Steurer M, Pall G, Richards S, Schwarzer G, Bohlius
J, Greil R. Purine Antagonists for Chronic Lymphocytic
Leukaemia. Cochrane Database of Systematic
Reviews 2006, Issue 3. Art. No.: CD004270. DOI:
10.1002/14651858.CD004270.pub2.
GRUPO L | Agentes antineoplásicos e inmunomoduladores
391
L